NCT00521443已完成不适用
Cryosurvival of Embryos From Dysmorphic Oocytes
V.K.V. American Hospital, Istanbul1 个研究点 分布在 1 个国家开始时间: 2007年8月27日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 试验地点
- 1
研究概览
简要总结
Various morphological abnormalities of human oocytes were reported to detrimentally affect embryo development. We observed development of frozen thawed embryos derived from oocytes with normal or abnormal morphological features to the blastocyst stage. Cytoplasmic abnormalities of the oocytes were found to negatively affect cryosurvival potential of the embryos.
研究设计
- 研究类型
- Observational
- 观察模型
- Defined Population
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 45 Years（Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Human embryos derived from morphologically normal or abnormal mature oocytes that fertilized normally by microinjection procedure.
- •Embryos were obtained from couples who refused to freeze their supernumerary embryos after fresh embryo transfer in an assisted reproduction treatment cycle.
排除标准
- •Embryos obtained after microinjection to immature oocytes taht were in vitro matured in culture.
- •Embryos obtained from abnormally fertilized zygotes.
研究者
研究点 (1)
Loading locations...
相似试验
招募中
Unknown
Checking the survival rate of sub zero preserved reproductive cells and embryos using zinc nanoparticlesCTRI/2023/07/055645Science and Engineering Research BoardSERB
已完成
不适用
Cryopreservation of human embryos in a modified cryoprotectant solutioIn Vitro Fertilisation (IVF) and Intra-Cytoplasmic Sperm Injection (ICSI)Pregnancy and ChildbirthFertilisationISRCTN93314892niversity of Aberdeen (UK)200
已完成
不适用
Oocyte Cryopreservation: The Impact of Cryopreservation on the Meiotic Spindle and Mitochondria of Human Oocytes.InfertilityNCT00716118West Coast Fertility Centers20
已完成
不适用
Day 3 Embryo Cryopreservation: Metabolic and Viability AnalysisFertilization in VitroPreservation of Supernumerary EmbryosNCT00608010V.K.V. American Hospital, Istanbul186
终止
不适用
Impact of Blastocyst Morphological Development and Blastocoele Re-expansion on Pregnancy Outcome After Using REKOVELLE®Controlled Ovarian StimulationNCT03697031Ferring Pharmaceuticals362